LTRN   $1.62  14.08% Market Closed

Lantern Pharma Inc.
Total Cash 33.26M
totalCashPerShare 3.09
EBITDA -19.53M
Total Debt 218.70K
quickRatio 7.23
currentRatio 7.671
Total Revenue
debtToEquity 0.707
Revenue/Share
ROA -0.28073
ROE -0.44823003
grossProfits
freeCashflow -8.71M
operatingCashflow -15.26M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 2.16M
forwardPE
floatShares 7.94M
sharesOutstanding 10.76M
sharesShort 176.91K
sharesShortPriorMonth 179.08K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.15%
heldPercentInstitutions 0.24%
Short Ratio help_outline 4.74%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 2.875
Price To Book help_outline 1.15
earningsQuarterlyGrowth
netIncomeToCommon -17.75M
trailingEps -1.65%
forwardEps -2.02%
enterpriseToEbitda -0.11
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.56 3Q 2024
institutionsCount 48
lastUpdated Nov. 7, 2024, 3:16 a.m.